NCI and the National Heart, Lung, and Blood Institute (NHLBI) cosponsored the meeting. Minasian continued, researchers have begun systematically to document the longer-term cardiovascular side effects of cancer treatments, also known as cardiotoxicities.Īt the workshop on improving outcomes in treatment-related cardiotoxicity, participants from government, academia, and the private sector identified gaps in current knowledge and discussed priorities for future research. “Patients diagnosed with cancer are living longer today than in the past, and many of these survivors are living long enough to develop late cardiovascular effects,” said Lori Minasian, M.D., deputy director of NCI’s Division of Cancer Prevention, in an interview. Some cardiac side effects, however, go undetected for years or even decades after a patient’s treatment has ended. Armenian, who treats children with cancer at City of Hope Comprehensive Cancer Center, noted that when a patient develops cardiac side effects during treatment, a doctor may modify the dose of a therapy or stop the therapy altogether. “Cancer therapies affect a number of organs and organ systems, including the heart,” said Saro Armenian, D.O., M.P.H., at the meeting. These side effects, including high blood pressure, abnormal heart rhythms, and heart failure, can be caused or exacerbated by chemotherapy and radiation therapy, as well as by newer forms of cancer treatment, such as targeted therapies and immunotherapies. In June, approximately 100 researchers attended a workshop on the campus of the National Institutes of Health (NIH) in Bethesda, MD, about an important but underappreciated side effect of some treatments for cancer: heart problems.Ĭertain cancer treatments can damage the heart and the cardiovascular system.
0 kommentar(er)
